Mogens Helweg Claesson

Mogens Helweg Claesson

No job title VIP


Publication year:
All
201 - 210 out of 221Page size: 10
Sort by: Title
  1. Published

    The ultrastructure of isoantibody-induced decay of human lymphocytes in vitro

    Claesson, Mogens Helweg, Ahrons, S. & Jorgensen, O., 1 Jan 1971, In: HLA. 1, 2, p. 94-103 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.

    Berntsen, A., Trepiakas, R., Wenandy, L., Geertsen, P. F., thor Straten, P., Andersen, M. H., Pedersen, Anders Elm, Claesson, Mogens Helweg, Lorentzen, T., Johansen, J. S. & Svane, I. M., 2008, In: Journal of Immunotherapy. 31, 8, p. 771-80 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Thymic epithelial cells. I. Expression of strong suppressive (veto) activity in mouse thymic epithelial cell cultures

    Claesson, Mogens Helweg & Ropke, C., 1 Dec 1990, In: Scandinavian Journal of Immunology. 32, 6, p. 595-600 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model

    Pedersen, Anders Elm, Gad, M., Kristensen, N. N., Haase, C., Nielsen, C. H. & Claesson, Mogens Helweg, 2007, In: Immunology. 121, 4, p. 526-32 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Transforming growth factor-beta messenger RNA and protein in murine colitis

    Whiting, C. V., Williams, A. M., Claesson, Mogens Helweg, Bregenholt, S., Reimann, J. & Bland, P. W., 1 Jun 2001, In: Journal of Histochemistry and Cytochemistry. 49, 6, p. 727-738 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4.

    Pedersen, Anders Elm, Buus, Søren & Claesson, Mogens Helweg, 2005, In: Cancer Letters. 235, 2, p. 229-38 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Tumor-associated antigens identified by mRNA expression profiling as tumor rejection epitopes.

    Andersen, M., Ruhwald, M., Thorn, M., Pedersen, Anders Elm, Mathiassen, S., Buus, S. & Claesson, Mogens Helweg, 2003, In: Journal of Immune Based Therapies and Vaccines. 1, 1, p. 1

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

    Mathiassen, S., Lauemøller, S. L., Ruhwald, M., Claesson, Mogens Helweg & Buus, Søren, 2001, In: European Journal of Immunology. 31, 4, p. 1239-46 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Tumor-infiltrating lymphocytes mediate lysis of autologous squamos cell carcinomas of the head and neck

    Hald, J., Rasmussen, N. & Claesson, Mogens Helweg, 1995, In: Cancer Immunology, Immunotherapy. 41, p. 243-250

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Tumorspecifikke antigener er en realitet

    Claesson, Mogens Helweg, 18 Aug 1997, In: Ugeskrift for Laeger. 159, 34, p. 5110-1 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...17 18 19 20 21 22 23 Next

ID: 5261